In our January issue of Pharmaceutical Executive
FEATURES
Cover Story
Pharm Exec’s 2018 Industry Forecast
Pharm Exec Editors
In our annual temperature check on the life sciences sector and its outlook for the months ahead, we explore eight trends that will shape the biopharma industry landscape in 2018. |
Interview
From Gleevec to CAR-T
PharmaBoardroom
Bruno Strigini, CEO of Novartis Oncology, talks about the company’s pioneering path in cancer—starting with Gleveec and continuing with last year’s approval of the first-ever CAR-T cell therapy—touching on the related broader issues such as pricing and value and new innovations in cancer science. |
US
Prices and Competition to Shape the Year Ahead
Jill Wechsler
States will continue to press for price controls, while FDA will tackle opioids and promote innovation. |
Technology
New Year, Next Steps in Digital Transformation
William King
Five predictions on evolution of data and predictive insights that could be critical for pharma go-to-market strategies. |
|
ALSO IN THIS ISSUE
CAR-T Concerns for Future Success
Lisa Henderson
The advent of immunocellular therapies marks a major milestone in medical innovation, but the path for these treatments in transforming patient care is still forming as they face challenges in clinical trials, pricing, and market acceptance …Read more
Food for Thought in Cancer Fight
Michelle Maskaly
Program puts a new—and very real—spin on patient nutrition …Read more
|
| |
| WEBCASTS |
| The Changing Market for Drugs to Treat Orphan Diseases |
| Through the Patient’s Eyes — Needs, Behaviors and the Science Behind It All |
Unlocking the Patient Voice: How Digital Technology Can Facilitate Effective Patient Data Capture in Real-World Data Programs
|
Regenerative Medicine: Overcoming Obstacles to Reimbursement and Market Access
|
Patient Centricity: Turning Rhetoric into Reality
|
Biologics Manufacturing – Is Your Company Ready?
|
Value-Based Engagement Models: Making Collaborations between Pharma and Health Systems Work
|
